Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
RARA [1] RARA 💬Acute myeloid leukemia
|
Isotretinoin Isotretinoin 💬Acute myeloid leukemia
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Adherens junction 💬 12 genes, 24 drugs (DrugBank) and 29 diseases |
EGFR [1] EGFR 💬Adherens junction
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Adherens junction
| Erlotinib | 094 [2] 94, 160 💬2. Adherens junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Adherens junction 💬 12 genes, 24 drugs (DrugBank) and 29 diseases |
EGFR [1] EGFR 💬Adherens junction
|
Erlotinib Erlotinib 💬Adherens junction
| Erlotinib | 094 [2] 94, 160 💬2. Adherens junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Adipocytokine signaling pathway 💬 16 genes, 38 drugs (DrugBank) and 104 diseases |
NR1C1 [1] NR1C1 💬Adipocytokine signaling pathway
|
Bezafibrate Bezafibrate 💬Adipocytokine signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬4. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Adipocytokine signaling pathway 💬 16 genes, 38 drugs (DrugBank) and 104 diseases |
TNF [1] TNF 💬Adipocytokine signaling pathway
|
Adalimumab Adalimumab 💬Adipocytokine signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬5. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | African trypanosomiasis 💬 10 genes, 24 drugs (DrugBank) and 62 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬African trypanosomiasis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬6. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | African trypanosomiasis 💬 10 genes, 24 drugs (DrugBank) and 62 diseases |
TNF [1] TNF 💬African trypanosomiasis
|
Adalimumab Adalimumab 💬African trypanosomiasis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬7. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
TNF [1] TNF 💬AGE-RAGE signaling pathway in diabetic complications
|
Adalimumab Adalimumab 💬AGE-RAGE signaling pathway in diabetic complications
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬8. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Alcoholic liver disease 💬 42 genes, 54 drugs (DrugBank) and 91 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Alcoholic liver disease
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬9. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Alcoholic liver disease 💬 42 genes, 54 drugs (DrugBank) and 91 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Ixekizumab Ixekizumab 💬Alcoholic liver disease
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬10. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Alcoholic liver disease 💬 42 genes, 54 drugs (DrugBank) and 91 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Secukinumab Secukinumab 💬Alcoholic liver disease
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬11. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Alcoholic liver disease 💬 42 genes, 54 drugs (DrugBank) and 91 diseases |
NR1C1 [1] NR1C1 💬Alcoholic liver disease
|
Bezafibrate Bezafibrate 💬Alcoholic liver disease
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬12. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Alcoholic liver disease 💬 42 genes, 54 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬Alcoholic liver disease
|
Adalimumab Adalimumab 💬Alcoholic liver disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬13. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Allograft rejection 💬 31 genes, 26 drugs (DrugBank) and 60 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Allograft rejection
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬14. Allograft rejection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | Allograft rejection 💬 31 genes, 26 drugs (DrugBank) and 60 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Allograft rejection
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬15. Allograft rejection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | Allograft rejection 💬 31 genes, 26 drugs (DrugBank) and 60 diseases |
TNF [1] TNF 💬Allograft rejection
|
Adalimumab Adalimumab 💬Allograft rejection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬16. Allograft rejection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Alzheimer disease
| Pimecrolimus | 160 [1] 160 💬17. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
TNF [1] TNF 💬Alzheimer disease
|
Adalimumab Adalimumab 💬Alzheimer disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬18. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 71 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Amoebiasis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬19. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 71 diseases |
TNF [1] TNF 💬Amoebiasis
|
Adalimumab Adalimumab 💬Amoebiasis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬20. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Amphetamine addiction
| Pimecrolimus | 160 [1] 160 💬21. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Atorvastatin calcium Atorvastatin calcium 💬AMPK signaling pathway
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬22. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Atorvastatin Atorvastatin 💬AMPK signaling pathway
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬22. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Lovastatin Lovastatin 💬AMPK signaling pathway
| Lovastatin | 006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬24. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Simvastatin Simvastatin 💬AMPK signaling pathway
| Simvastatin | 006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬25. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Amyotrophic lateral sclerosis
| Pimecrolimus | 160 [1] 160 💬26. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
TNF [1] TNF 💬Amyotrophic lateral sclerosis
|
Adalimumab Adalimumab 💬Amyotrophic lateral sclerosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬27. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | Antigen processing and presentation 💬 26 genes, 17 drugs (DrugBank) and 61 diseases |
TNF [1] TNF 💬Antigen processing and presentation
|
Adalimumab Adalimumab 💬Antigen processing and presentation
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬28. Antigen processing and presentation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | Apoptosis 💬 17 genes, 31 drugs (DrugBank) and 64 diseases |
TNF [1] TNF 💬Apoptosis
|
Adalimumab Adalimumab 💬Apoptosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬29. Apoptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | Arachidonic acid metabolism 💬 5 genes, 25 drugs (DrugBank) and 44 diseases |
ALOX5 [1] ALOX5 💬Arachidonic acid metabolism
|
Zileuton Zileuton 💬Arachidonic acid metabolism
| Zileuton | 085 [3] 85, 160, 164 💬30. Arachidonic acid metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Asthma 💬 21 genes, 25 drugs (DrugBank) and 58 diseases |
TNF [1] TNF 💬Asthma
|
Adalimumab Adalimumab 💬Asthma
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬31. Asthma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Autoimmune thyroid disease 💬 42 genes, 18 drugs (DrugBank) and 37 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Autoimmune thyroid disease
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬32. Autoimmune thyroid disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Axon guidance
| Pimecrolimus | 160 [1] 160 💬33. Axon guidance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
34 | B cell receptor signaling pathway 💬 19 genes, 39 drugs (DrugBank) and 68 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬B cell receptor signaling pathway
| Pimecrolimus | 160 [1] 160 💬34. B cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Atorvastatin calcium Atorvastatin calcium 💬Bile secretion
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬35. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Atorvastatin Atorvastatin 💬Bile secretion
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬35. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Lovastatin Lovastatin 💬Bile secretion
| Lovastatin | 006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬37. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Simvastatin Simvastatin 💬Bile secretion
| Simvastatin | 006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬38. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
39 | Bladder cancer 💬 11 genes, 27 drugs (DrugBank) and 33 diseases |
EGFR [1] EGFR 💬Bladder cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Bladder cancer
| Erlotinib | 094 [2] 94, 160 💬39. Bladder cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 | Bladder cancer 💬 11 genes, 27 drugs (DrugBank) and 33 diseases |
EGFR [1] EGFR 💬Bladder cancer
|
Erlotinib Erlotinib 💬Bladder cancer
| Erlotinib | 094 [2] 94, 160 💬39. Bladder cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
EGFR [1] EGFR 💬Breast cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Breast cancer
| Erlotinib | 094 [2] 94, 160 💬41. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
EGFR [1] EGFR 💬Breast cancer
|
Erlotinib Erlotinib 💬Breast cancer
| Erlotinib | 094 [2] 94, 160 💬41. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬C-type lectin receptor signaling pathway
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬43. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬C-type lectin receptor signaling pathway
| Pimecrolimus | 160 [1] 160 💬44. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
TNF [1] TNF 💬C-type lectin receptor signaling pathway
|
Adalimumab Adalimumab 💬C-type lectin receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬45. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EGFR [1] EGFR 💬Calcium signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Calcium signaling pathway
| Erlotinib | 094 [2] 94, 160 💬46. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EGFR [1] EGFR 💬Calcium signaling pathway
|
Erlotinib Erlotinib 💬Calcium signaling pathway
| Erlotinib | 094 [2] 94, 160 💬46. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Calcium signaling pathway
| Pimecrolimus | 160 [1] 160 💬48. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
49 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
NR1C1 [1] NR1C1 💬cAMP signaling pathway
|
Bezafibrate Bezafibrate 💬cAMP signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬49. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
50 | Cell adhesion molecules 💬 43 genes, 34 drugs (DrugBank) and 43 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Cell adhesion molecules
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬50. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
51 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Cellular senescence
| Pimecrolimus | 160 [1] 160 💬51. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
52 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
EGFR [1] EGFR 💬Central carbon metabolism in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Central carbon metabolism in cancer
| Erlotinib | 094 [2] 94, 160 💬52. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
53 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
EGFR [1] EGFR 💬Central carbon metabolism in cancer
|
Erlotinib Erlotinib 💬Central carbon metabolism in cancer
| Erlotinib | 094 [2] 94, 160 💬52. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
54 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬cGMP-PKG signaling pathway
| Pimecrolimus | 160 [1] 160 💬54. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
55 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Chagas disease
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬55. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Chagas disease
|
Adalimumab Adalimumab 💬Chagas disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬56. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
57 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Chemical carcinogenesis - reactive oxygen species
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Chemical carcinogenesis - reactive oxygen species
| Erlotinib | 094 [2] 94, 160 💬57. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
58 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Chemical carcinogenesis - reactive oxygen species
|
Erlotinib Erlotinib 💬Chemical carcinogenesis - reactive oxygen species
| Erlotinib | 094 [2] 94, 160 💬57. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
59 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
EGFR [1] EGFR 💬Chemical carcinogenesis - receptor activation
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Chemical carcinogenesis - receptor activation
| Erlotinib | 094 [2] 94, 160 💬59. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
60 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
EGFR [1] EGFR 💬Chemical carcinogenesis - receptor activation
|
Erlotinib Erlotinib 💬Chemical carcinogenesis - receptor activation
| Erlotinib | 094 [2] 94, 160 💬59. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
61 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
NR1C1 [1] NR1C1 💬Chemical carcinogenesis - receptor activation
|
Bezafibrate Bezafibrate 💬Chemical carcinogenesis - receptor activation
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬61. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
62 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
EGFR [1] EGFR 💬Choline metabolism in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Choline metabolism in cancer
| Erlotinib | 094 [2] 94, 160 💬62. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
EGFR [1] EGFR 💬Choline metabolism in cancer
|
Erlotinib Erlotinib 💬Choline metabolism in cancer
| Erlotinib | 094 [2] 94, 160 💬62. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
64 | Colorectal cancer 💬 14 genes, 26 drugs (DrugBank) and 59 diseases |
EGFR [1] EGFR 💬Colorectal cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Colorectal cancer
| Erlotinib | 094 [2] 94, 160 💬64. Colorectal cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 | Colorectal cancer 💬 14 genes, 26 drugs (DrugBank) and 59 diseases |
EGFR [1] EGFR 💬Colorectal cancer
|
Erlotinib Erlotinib 💬Colorectal cancer
| Erlotinib | 094 [2] 94, 160 💬64. Colorectal cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
EGFR [1] EGFR 💬Coronavirus disease - COVID-19
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Coronavirus disease - COVID-19
| Erlotinib | 094 [2] 94, 160 💬66. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
67 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
EGFR [1] EGFR 💬Coronavirus disease - COVID-19
|
Erlotinib Erlotinib 💬Coronavirus disease - COVID-19
| Erlotinib | 094 [2] 94, 160 💬66. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
68 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Coronavirus disease - COVID-19
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬68. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
69 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
TNF [1] TNF 💬Coronavirus disease - COVID-19
|
Adalimumab Adalimumab 💬Coronavirus disease - COVID-19
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬69. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
70 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
TYK2 [1] TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Coronavirus disease - COVID-19
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬70. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
EGFR [1] EGFR 💬Cushing syndrome
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Cushing syndrome
| Erlotinib | 094 [2] 94, 160 💬71. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
EGFR [1] EGFR 💬Cushing syndrome
|
Erlotinib Erlotinib 💬Cushing syndrome
| Erlotinib | 094 [2] 94, 160 💬71. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
73 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Cytokine-cytokine receptor interaction
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬73. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
74 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL17A [1] IL17A 💬Cytokine-cytokine receptor interaction
|
Ixekizumab Ixekizumab 💬Cytokine-cytokine receptor interaction
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬74. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
75 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL17A [1] IL17A 💬Cytokine-cytokine receptor interaction
|
Secukinumab Secukinumab 💬Cytokine-cytokine receptor interaction
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬75. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
76 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL1RL2 [1] IL1RL2 💬Cytokine-cytokine receptor interaction
|
Spesolimab Spesolimab 💬Cytokine-cytokine receptor interaction
| Spesolimab | 037 [5] 37, 96, 97, 160, 269 💬76. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
77 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL4R [1] IL4R 💬Cytokine-cytokine receptor interaction
|
Dupilumab Dupilumab 💬Cytokine-cytokine receptor interaction
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬77. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
78 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
TNF [1] TNF 💬Cytokine-cytokine receptor interaction
|
Adalimumab Adalimumab 💬Cytokine-cytokine receptor interaction
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬78. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
79 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
NR1C1 [1] NR1C1 💬Diabetic cardiomyopathy
|
Bezafibrate Bezafibrate 💬Diabetic cardiomyopathy
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬79. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
80 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
TNF [1] TNF 💬Dilated cardiomyopathy
|
Adalimumab Adalimumab 💬Dilated cardiomyopathy
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬80. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
81 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
PPP3C [3] PPP3C, PPP3C, PPP3C 💬
|
Pimecrolimus Pimecrolimus 💬Dopaminergic synapse
| Pimecrolimus | 160 [1] 160 💬81. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
82 | Efferocytosis 💬 29 genes, 74 drugs (DrugBank) and 93 diseases |
ALOX5 [1] ALOX5 💬Efferocytosis
|
Zileuton Zileuton 💬Efferocytosis
| Zileuton | 085 [3] 85, 160, 164 💬82. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
83 | Endocytosis 💬 22 genes, 37 drugs (DrugBank) and 54 diseases |
EGFR [1] EGFR 💬Endocytosis
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Endocytosis
| Erlotinib | 094 [2] 94, 160 💬83. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
84 | Endocytosis 💬 22 genes, 37 drugs (DrugBank) and 54 diseases |
EGFR [1] EGFR 💬Endocytosis
|
Erlotinib Erlotinib 💬Endocytosis
| Erlotinib | 094 [2] 94, 160 💬83. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
85 | Endometrial cancer 💬 10 genes, 20 drugs (DrugBank) and 28 diseases |
EGFR [1] EGFR 💬Endometrial cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Endometrial cancer
| Erlotinib | 094 [2] 94, 160 💬85. Endometrial cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
86 | Endometrial cancer 💬 10 genes, 20 drugs (DrugBank) and 28 diseases |
EGFR [1] EGFR 💬Endometrial cancer
|
Erlotinib Erlotinib 💬Endometrial cancer
| Erlotinib | 094 [2] 94, 160 💬85. Endometrial cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
87 | Epithelial cell signaling in Helicobacter pylori infection 💬 12 genes, 19 drugs (DrugBank) and 26 diseases |
EGFR [1] EGFR 💬Epithelial cell signaling in Helicobacter pylori infection
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Epithelial cell signaling in Helicobacter pylori infection
| Erlotinib | 094 [2] 94, 160 💬87. Epithelial cell signaling in Helicobacter pylori infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
88 | Epithelial cell signaling in Helicobacter pylori infection 💬 12 genes, 19 drugs (DrugBank) and 26 diseases |
EGFR [1] EGFR 💬Epithelial cell signaling in Helicobacter pylori infection
|
Erlotinib Erlotinib 💬Epithelial cell signaling in Helicobacter pylori infection
| Erlotinib | 094 [2] 94, 160 💬87. Epithelial cell signaling in Helicobacter pylori infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
89 | Epstein-Barr virus infection 💬 67 genes, 90 drugs (DrugBank) and 82 diseases |
TNF [1] TNF 💬Epstein-Barr virus infection
|
Adalimumab Adalimumab 💬Epstein-Barr virus infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬89. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
90 | Epstein-Barr virus infection 💬 67 genes, 90 drugs (DrugBank) and 82 diseases |
TYK2 [1] TYK2 💬Epstein-Barr virus infection
|
Deucravacitinib Deucravacitinib 💬Epstein-Barr virus infection
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬90. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
91 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
EGFR [1] EGFR 💬ErbB signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬ErbB signaling pathway
| Erlotinib | 094 [2] 94, 160 💬91. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
92 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
EGFR [1] EGFR 💬ErbB signaling pathway
|
Erlotinib Erlotinib 💬ErbB signaling pathway
| Erlotinib | 094 [2] 94, 160 💬91. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
93 | Estrogen signaling pathway 💬 21 genes, 81 drugs (DrugBank) and 73 diseases |
EGFR [1] EGFR 💬Estrogen signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Estrogen signaling pathway
| Erlotinib | 094 [2] 94, 160 💬93. Estrogen signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
94 | Estrogen signaling pathway 💬 21 genes, 81 drugs (DrugBank) and 73 diseases |
EGFR [1] EGFR 💬Estrogen signaling pathway
|
Erlotinib Erlotinib 💬Estrogen signaling pathway
| Erlotinib | 094 [2] 94, 160 💬93. Estrogen signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
95 | Estrogen signaling pathway 💬 21 genes, 81 drugs (DrugBank) and 73 diseases |
RARA [1] RARA 💬Estrogen signaling pathway
|
Isotretinoin Isotretinoin 💬Estrogen signaling pathway
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬95. Estrogen signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
96 | Fc epsilon RI signaling pathway 💬 19 genes, 50 drugs (DrugBank) and 68 diseases |
ALOX5 [1] ALOX5 💬Fc epsilon RI signaling pathway
|
Zileuton Zileuton 💬Fc epsilon RI signaling pathway
| Zileuton | 085 [3] 85, 160, 164 💬96. Fc epsilon RI signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
97 | Fc epsilon RI signaling pathway 💬 19 genes, 50 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Fc epsilon RI signaling pathway
|
Adalimumab Adalimumab 💬Fc epsilon RI signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬97. Fc epsilon RI signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
98 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
TNF [1] TNF 💬Fluid shear stress and atherosclerosis
|
Adalimumab Adalimumab 💬Fluid shear stress and atherosclerosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬98. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
99 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
EGFR [1] EGFR 💬Focal adhesion
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Focal adhesion
| Erlotinib | 094 [2] 94, 160 💬99. Focal adhesion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
100 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
EGFR [1] EGFR 💬Focal adhesion
|
Erlotinib Erlotinib 💬Focal adhesion
| Erlotinib | 094 [2] 94, 160 💬99. Focal adhesion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
101 | FoxO signaling pathway 💬 25 genes, 43 drugs (DrugBank) and 60 diseases |
EGFR [1] EGFR 💬FoxO signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬FoxO signaling pathway
| Erlotinib | 094 [2] 94, 160 💬101. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
102 | FoxO signaling pathway 💬 25 genes, 43 drugs (DrugBank) and 60 diseases |
EGFR [1] EGFR 💬FoxO signaling pathway
|
Erlotinib Erlotinib 💬FoxO signaling pathway
| Erlotinib | 094 [2] 94, 160 💬101. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
103 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
EGFR [1] EGFR 💬Gap junction
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Gap junction
| Erlotinib | 094 [2] 94, 160 💬103. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
104 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
EGFR [1] EGFR 💬Gap junction
|
Erlotinib Erlotinib 💬Gap junction
| Erlotinib | 094 [2] 94, 160 💬103. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
105 | Gastric cancer 💬 22 genes, 40 drugs (DrugBank) and 66 diseases |
EGFR [1] EGFR 💬Gastric cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Gastric cancer
| Erlotinib | 094 [2] 94, 160 💬105. Gastric cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
106 | Gastric cancer 💬 22 genes, 40 drugs (DrugBank) and 66 diseases |
EGFR [1] EGFR 💬Gastric cancer
|
Erlotinib Erlotinib 💬Gastric cancer
| Erlotinib | 094 [2] 94, 160 💬105. Gastric cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
107 | Gastric cancer 💬 22 genes, 40 drugs (DrugBank) and 66 diseases |
RARB [1] RARB 💬Gastric cancer
|
Isotretinoin Isotretinoin 💬Gastric cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬107. Gastric cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
108 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
EGFR [1] EGFR 💬Glioma
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Glioma
| Erlotinib | 094 [2] 94, 160 💬108. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
109 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
EGFR [1] EGFR 💬Glioma
|
Erlotinib Erlotinib 💬Glioma
| Erlotinib | 094 [2] 94, 160 💬108. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
110 | Glucagon signaling pathway 💬 14 genes, 23 drugs (DrugBank) and 82 diseases |
NR1C1 [1] NR1C1 💬Glucagon signaling pathway
|
Bezafibrate Bezafibrate 💬Glucagon signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬110. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
111 | Glucagon signaling pathway 💬 14 genes, 23 drugs (DrugBank) and 82 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Glucagon signaling pathway
| Pimecrolimus | 160 [1] 160 💬111. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
112 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Glutamatergic synapse
| Pimecrolimus | 160 [1] 160 💬112. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
113 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 42 diseases |
EGFR [1] EGFR 💬GnRH signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬GnRH signaling pathway
| Erlotinib | 094 [2] 94, 160 💬113. GnRH signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
114 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 42 diseases |
EGFR [1] EGFR 💬GnRH signaling pathway
|
Erlotinib Erlotinib 💬GnRH signaling pathway
| Erlotinib | 094 [2] 94, 160 💬113. GnRH signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
115 | Graft-versus-host disease 💬 28 genes, 25 drugs (DrugBank) and 64 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Graft-versus-host disease
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬115. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
116 | Graft-versus-host disease 💬 28 genes, 25 drugs (DrugBank) and 64 diseases |
TNF [1] TNF 💬Graft-versus-host disease
|
Adalimumab Adalimumab 💬Graft-versus-host disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬116. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
117 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
IL4R [1] IL4R 💬Hematopoietic cell lineage
|
Dupilumab Dupilumab 💬Hematopoietic cell lineage
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬117. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
118 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
TNF [1] TNF 💬Hematopoietic cell lineage
|
Adalimumab Adalimumab 💬Hematopoietic cell lineage
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬118. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
119 | Hepatitis B 💬 43 genes, 65 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Hepatitis B
|
Adalimumab Adalimumab 💬Hepatitis B
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬119. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
120 | Hepatitis B 💬 43 genes, 65 drugs (DrugBank) and 87 diseases |
TYK2 [1] TYK2 💬Hepatitis B
|
Deucravacitinib Deucravacitinib 💬Hepatitis B
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬120. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
121 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
EGFR [1] EGFR 💬Hepatitis C
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Hepatitis C
| Erlotinib | 094 [2] 94, 160 💬121. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
122 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
EGFR [1] EGFR 💬Hepatitis C
|
Erlotinib Erlotinib 💬Hepatitis C
| Erlotinib | 094 [2] 94, 160 💬121. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
123 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
NR1C1 [1] NR1C1 💬Hepatitis C
|
Bezafibrate Bezafibrate 💬Hepatitis C
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬123. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
124 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Hepatitis C
|
Adalimumab Adalimumab 💬Hepatitis C
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬124. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
125 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
TYK2 [1] TYK2 💬Hepatitis C
|
Deucravacitinib Deucravacitinib 💬Hepatitis C
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬125. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
126 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
EGFR [1] EGFR 💬Hepatocellular carcinoma
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Hepatocellular carcinoma
| Erlotinib | 094 [2] 94, 160 💬126. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
127 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
EGFR [1] EGFR 💬Hepatocellular carcinoma
|
Erlotinib Erlotinib 💬Hepatocellular carcinoma
| Erlotinib | 094 [2] 94, 160 💬126. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
128 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Herpes simplex virus 1 infection
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬128. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
129 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
TNF [1] TNF 💬Herpes simplex virus 1 infection
|
Adalimumab Adalimumab 💬Herpes simplex virus 1 infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬129. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
130 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
TYK2 [1] TYK2 💬Herpes simplex virus 1 infection
|
Deucravacitinib Deucravacitinib 💬Herpes simplex virus 1 infection
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬130. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
131 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
EGFR [1] EGFR 💬HIF-1 signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬HIF-1 signaling pathway
| Erlotinib | 094 [2] 94, 160 💬131. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
132 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
EGFR [1] EGFR 💬HIF-1 signaling pathway
|
Erlotinib Erlotinib 💬HIF-1 signaling pathway
| Erlotinib | 094 [2] 94, 160 💬131. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
133 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
EGFR [1] EGFR 💬Human cytomegalovirus infection
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Human cytomegalovirus infection
| Erlotinib | 094 [2] 94, 160 💬133. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
134 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
EGFR [1] EGFR 💬Human cytomegalovirus infection
|
Erlotinib Erlotinib 💬Human cytomegalovirus infection
| Erlotinib | 094 [2] 94, 160 💬133. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
135 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Human cytomegalovirus infection
| Pimecrolimus | 160 [1] 160 💬135. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
136 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
TNF [1] TNF 💬Human cytomegalovirus infection
|
Adalimumab Adalimumab 💬Human cytomegalovirus infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬136. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
137 | Human immunodeficiency virus 1 infection 💬 50 genes, 57 drugs (DrugBank) and 95 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Human immunodeficiency virus 1 infection
| Pimecrolimus | 160 [1] 160 💬137. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
138 | Human immunodeficiency virus 1 infection 💬 50 genes, 57 drugs (DrugBank) and 95 diseases |
TNF [1] TNF 💬Human immunodeficiency virus 1 infection
|
Adalimumab Adalimumab 💬Human immunodeficiency virus 1 infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬138. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
139 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
EGFR [1] EGFR 💬Human papillomavirus infection
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Human papillomavirus infection
| Erlotinib | 094 [2] 94, 160 💬139. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
140 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
EGFR [1] EGFR 💬Human papillomavirus infection
|
Erlotinib Erlotinib 💬Human papillomavirus infection
| Erlotinib | 094 [2] 94, 160 💬139. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
141 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
TNF [1] TNF 💬Human papillomavirus infection
|
Adalimumab Adalimumab 💬Human papillomavirus infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬141. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
142 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
TYK2 [1] TYK2 💬Human papillomavirus infection
|
Deucravacitinib Deucravacitinib 💬Human papillomavirus infection
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬142. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
143 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Human T-cell leukemia virus 1 infection
| Pimecrolimus | 160 [1] 160 💬143. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
144 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
TNF [1] TNF 💬Human T-cell leukemia virus 1 infection
|
Adalimumab Adalimumab 💬Human T-cell leukemia virus 1 infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬144. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
145 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
TNF [1] TNF 💬Hypertrophic cardiomyopathy
|
Adalimumab Adalimumab 💬Hypertrophic cardiomyopathy
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬145. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
146 | IL-17 signaling pathway 💬 20 genes, 61 drugs (DrugBank) and 86 diseases |
IL17A [1] IL17A 💬IL-17 signaling pathway
|
Ixekizumab Ixekizumab 💬IL-17 signaling pathway
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬146. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
147 | IL-17 signaling pathway 💬 20 genes, 61 drugs (DrugBank) and 86 diseases |
IL17A [1] IL17A 💬IL-17 signaling pathway
|
Secukinumab Secukinumab 💬IL-17 signaling pathway
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬147. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
148 | IL-17 signaling pathway 💬 20 genes, 61 drugs (DrugBank) and 86 diseases |
TNF [1] TNF 💬IL-17 signaling pathway
|
Adalimumab Adalimumab 💬IL-17 signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬148. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
149 | Inflammatory bowel disease 💬 37 genes, 46 drugs (DrugBank) and 70 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Inflammatory bowel disease
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬149. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
150 | Inflammatory bowel disease 💬 37 genes, 46 drugs (DrugBank) and 70 diseases |
IL17A [1] IL17A 💬Inflammatory bowel disease
|
Ixekizumab Ixekizumab 💬Inflammatory bowel disease
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬150. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
151 | Inflammatory bowel disease 💬 37 genes, 46 drugs (DrugBank) and 70 diseases |
IL17A [1] IL17A 💬Inflammatory bowel disease
|
Secukinumab Secukinumab 💬Inflammatory bowel disease
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬151. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
152 | Inflammatory bowel disease 💬 37 genes, 46 drugs (DrugBank) and 70 diseases |
IL4R [1] IL4R 💬Inflammatory bowel disease
|
Dupilumab Dupilumab 💬Inflammatory bowel disease
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬152. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
153 | Inflammatory bowel disease 💬 37 genes, 46 drugs (DrugBank) and 70 diseases |
TNF [1] TNF 💬Inflammatory bowel disease
|
Adalimumab Adalimumab 💬Inflammatory bowel disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬153. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
154 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Influenza A
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬154. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
155 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
TNF [1] TNF 💬Influenza A
|
Adalimumab Adalimumab 💬Influenza A
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬155. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
156 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
TYK2 [1] TYK2 💬Influenza A
|
Deucravacitinib Deucravacitinib 💬Influenza A
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬156. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
157 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 100 diseases |
NR1C1 [1] NR1C1 💬Insulin resistance
|
Bezafibrate Bezafibrate 💬Insulin resistance
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬157. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
158 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 100 diseases |
TNF [1] TNF 💬Insulin resistance
|
Adalimumab Adalimumab 💬Insulin resistance
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬158. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
159 | Intestinal immune network for IgA production 💬 33 genes, 40 drugs (DrugBank) and 51 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Intestinal immune network for IgA production
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬159. Intestinal immune network for IgA production
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
160 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
EGFR [1] EGFR 💬JAK-STAT signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬JAK-STAT signaling pathway
| Erlotinib | 094 [2] 94, 160 💬160. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
161 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
EGFR [1] EGFR 💬JAK-STAT signaling pathway
|
Erlotinib Erlotinib 💬JAK-STAT signaling pathway
| Erlotinib | 094 [2] 94, 160 💬160. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
162 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬JAK-STAT signaling pathway
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬162. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
163 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
IL4R [1] IL4R 💬JAK-STAT signaling pathway
|
Dupilumab Dupilumab 💬JAK-STAT signaling pathway
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬163. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
164 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
TYK2 [1] TYK2 💬JAK-STAT signaling pathway
|
Deucravacitinib Deucravacitinib 💬JAK-STAT signaling pathway
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬164. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
165 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
CD86 [1] CD86 💬Kaposi sarcoma-associated herpesvirus infection
|
Abatacept Abatacept 💬Kaposi sarcoma-associated herpesvirus infection
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬165. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
166 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Kaposi sarcoma-associated herpesvirus infection
| Pimecrolimus | 160 [1] 160 💬166. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
167 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
TYK2 [1] TYK2 💬Kaposi sarcoma-associated herpesvirus infection
|
Deucravacitinib Deucravacitinib 💬Kaposi sarcoma-associated herpesvirus infection
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬167. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
168 | Legionellosis 💬 9 genes, 23 drugs (DrugBank) and 64 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Legionellosis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬168. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
169 | Legionellosis 💬 9 genes, 23 drugs (DrugBank) and 64 diseases |
TNF [1] TNF 💬Legionellosis
|
Adalimumab Adalimumab 💬Legionellosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬169. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
170 | Leishmaniasis 💬 40 genes, 68 drugs (DrugBank) and 102 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Leishmaniasis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬170. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
171 | Leishmaniasis 💬 40 genes, 68 drugs (DrugBank) and 102 diseases |
TNF [1] TNF 💬Leishmaniasis
|
Adalimumab Adalimumab 💬Leishmaniasis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬171. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
172 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Lipid and atherosclerosis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬172. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
173 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Lipid and atherosclerosis
| Pimecrolimus | 160 [1] 160 💬173. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
174 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
TNF [1] TNF 💬Lipid and atherosclerosis
|
Adalimumab Adalimumab 💬Lipid and atherosclerosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬174. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
175 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Long-term potentiation
| Pimecrolimus | 160 [1] 160 💬175. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
176 | Malaria 💬 16 genes, 32 drugs (DrugBank) and 71 diseases |
IL12A [1] IL12A 💬Malaria
|
Ustekinumab Ustekinumab 💬Malaria
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬176. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
177 | Malaria 💬 16 genes, 32 drugs (DrugBank) and 71 diseases |
TNF [1] TNF 💬Malaria
|
Adalimumab Adalimumab 💬Malaria
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬177. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
178 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
EGFR [1] EGFR 💬MAPK signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬MAPK signaling pathway
| Erlotinib | 094 [2] 94, 160 💬178. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
179 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
EGFR [1] EGFR 💬MAPK signaling pathway
|
Erlotinib Erlotinib 💬MAPK signaling pathway
| Erlotinib | 094 [2] 94, 160 💬178. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
180 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬MAPK signaling pathway
| Pimecrolimus | 160 [1] 160 💬180. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
181 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
TNF [1] TNF 💬MAPK signaling pathway
|
Adalimumab Adalimumab 💬MAPK signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬181. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
182 | Measles 💬 42 genes, 63 drugs (DrugBank) and 68 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Measles
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬182. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
183 | Measles 💬 42 genes, 63 drugs (DrugBank) and 68 diseases |
TYK2 [1] TYK2 💬Measles
|
Deucravacitinib Deucravacitinib 💬Measles
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬183. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
184 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
EGFR [1] EGFR 💬Melanoma
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Melanoma
| Erlotinib | 094 [2] 94, 160 💬184. Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
185 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
EGFR [1] EGFR 💬Melanoma
|
Erlotinib Erlotinib 💬Melanoma
| Erlotinib | 094 [2] 94, 160 💬184. Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
186 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
EGFR [1] EGFR 💬MicroRNAs in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬MicroRNAs in cancer
| Erlotinib | 094 [2] 94, 160 💬186. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
187 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
EGFR [1] EGFR 💬MicroRNAs in cancer
|
Erlotinib Erlotinib 💬MicroRNAs in cancer
| Erlotinib | 094 [2] 94, 160 💬186. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
188 | mTOR signaling pathway 💬 14 genes, 33 drugs (DrugBank) and 95 diseases |
TNF [1] TNF 💬mTOR signaling pathway
|
Adalimumab Adalimumab 💬mTOR signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬188. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
189 | Natural killer cell mediated cytotoxicity 💬 44 genes, 50 drugs (DrugBank) and 86 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Natural killer cell mediated cytotoxicity
| Pimecrolimus | 160 [1] 160 💬189. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
190 | Natural killer cell mediated cytotoxicity 💬 44 genes, 50 drugs (DrugBank) and 86 diseases |
TNF [1] TNF 💬Natural killer cell mediated cytotoxicity
|
Adalimumab Adalimumab 💬Natural killer cell mediated cytotoxicity
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬190. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
191 | Necroptosis 💬 32 genes, 52 drugs (DrugBank) and 77 diseases |
TNF [1] TNF 💬Necroptosis
|
Adalimumab Adalimumab 💬Necroptosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬191. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
192 | Necroptosis 💬 32 genes, 52 drugs (DrugBank) and 77 diseases |
TYK2 [1] TYK2 💬Necroptosis
|
Deucravacitinib Deucravacitinib 💬Necroptosis
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬192. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
193 | NF-kappa B signaling pathway 💬 22 genes, 77 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬NF-kappa B signaling pathway
|
Adalimumab Adalimumab 💬NF-kappa B signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬193. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
194 | NOD-like receptor signaling pathway 💬 32 genes, 51 drugs (DrugBank) and 74 diseases |
TNF [1] TNF 💬NOD-like receptor signaling pathway
|
Adalimumab Adalimumab 💬NOD-like receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬194. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
195 | NOD-like receptor signaling pathway 💬 32 genes, 51 drugs (DrugBank) and 74 diseases |
TYK2 [1] TYK2 💬NOD-like receptor signaling pathway
|
Deucravacitinib Deucravacitinib 💬NOD-like receptor signaling pathway
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬195. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
196 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
NR1C1 [1] NR1C1 💬Non-alcoholic fatty liver disease
|
Bezafibrate Bezafibrate 💬Non-alcoholic fatty liver disease
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬196. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
197 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
TNF [1] TNF 💬Non-alcoholic fatty liver disease
|
Adalimumab Adalimumab 💬Non-alcoholic fatty liver disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬197. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
198 | Non-small cell lung cancer 💬 21 genes, 40 drugs (DrugBank) and 58 diseases |
EGFR [1] EGFR 💬Non-small cell lung cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Non-small cell lung cancer
| Erlotinib | 094 [2] 94, 160 💬198. Non-small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
199 | Non-small cell lung cancer 💬 21 genes, 40 drugs (DrugBank) and 58 diseases |
EGFR [1] EGFR 💬Non-small cell lung cancer
|
Erlotinib Erlotinib 💬Non-small cell lung cancer
| Erlotinib | 094 [2] 94, 160 💬198. Non-small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
200 | Non-small cell lung cancer 💬 21 genes, 40 drugs (DrugBank) and 58 diseases |
RARB [1] RARB 💬Non-small cell lung cancer
|
Isotretinoin Isotretinoin 💬Non-small cell lung cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬200. Non-small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
201 | Oocyte meiosis 💬 14 genes, 39 drugs (DrugBank) and 77 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Oocyte meiosis
| Pimecrolimus | 160 [1] 160 💬201. Oocyte meiosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
202 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Osteoclast differentiation
| Pimecrolimus | 160 [1] 160 💬202. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
203 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
TNF [1] TNF 💬Osteoclast differentiation
|
Adalimumab Adalimumab 💬Osteoclast differentiation
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬203. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
204 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
TYK2 [1] TYK2 💬Osteoclast differentiation
|
Deucravacitinib Deucravacitinib 💬Osteoclast differentiation
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬204. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
205 | Ovarian steroidogenesis 💬 7 genes, 34 drugs (DrugBank) and 53 diseases |
ALOX5 [1] ALOX5 💬Ovarian steroidogenesis
|
Zileuton Zileuton 💬Ovarian steroidogenesis
| Zileuton | 085 [3] 85, 160, 164 💬205. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
206 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
EGFR [1] EGFR 💬Oxytocin signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Oxytocin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬206. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
207 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
EGFR [1] EGFR 💬Oxytocin signaling pathway
|
Erlotinib Erlotinib 💬Oxytocin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬206. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
208 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Oxytocin signaling pathway
| Pimecrolimus | 160 [1] 160 💬208. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
209 | Pancreatic cancer 💬 19 genes, 40 drugs (DrugBank) and 84 diseases |
EGFR [1] EGFR 💬Pancreatic cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Pancreatic cancer
| Erlotinib | 094 [2] 94, 160 💬209. Pancreatic cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
210 | Pancreatic cancer 💬 19 genes, 40 drugs (DrugBank) and 84 diseases |
EGFR [1] EGFR 💬Pancreatic cancer
|
Erlotinib Erlotinib 💬Pancreatic cancer
| Erlotinib | 094 [2] 94, 160 💬209. Pancreatic cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
211 | Parathyroid hormone synthesis, secretion and action 💬 22 genes, 58 drugs (DrugBank) and 72 diseases |
EGFR [1] EGFR 💬Parathyroid hormone synthesis, secretion and action
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Parathyroid hormone synthesis, secretion and action
| Erlotinib | 094 [2] 94, 160 💬211. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
212 | Parathyroid hormone synthesis, secretion and action 💬 22 genes, 58 drugs (DrugBank) and 72 diseases |
EGFR [1] EGFR 💬Parathyroid hormone synthesis, secretion and action
|
Erlotinib Erlotinib 💬Parathyroid hormone synthesis, secretion and action
| Erlotinib | 094 [2] 94, 160 💬211. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
213 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
TNF [1] TNF 💬Pathogenic Escherichia coli infection
|
Adalimumab Adalimumab 💬Pathogenic Escherichia coli infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬213. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
214 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EGFR [1] EGFR 💬Pathways in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Pathways in cancer
| Erlotinib | 094 [2] 94, 160 💬214. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
215 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EGFR [1] EGFR 💬Pathways in cancer
|
Erlotinib Erlotinib 💬Pathways in cancer
| Erlotinib | 094 [2] 94, 160 💬214. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
216 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Pathways in cancer
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬216. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
217 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
IL4R [1] IL4R 💬Pathways in cancer
|
Dupilumab Dupilumab 💬Pathways in cancer
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬217. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
218 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
RARA [2] RARA, RARB 💬
|
Isotretinoin Isotretinoin 💬Pathways in cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬218. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
219 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Pathways of neurodegeneration - multiple diseases
| Pimecrolimus | 160 [1] 160 💬219. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
220 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
TNF [1] TNF 💬Pathways of neurodegeneration - multiple diseases
|
Adalimumab Adalimumab 💬Pathways of neurodegeneration - multiple diseases
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬220. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
221 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 35 genes, 66 drugs (DrugBank) and 100 diseases |
EGFR [1] EGFR 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Erlotinib | 094 [2] 94, 160 💬221. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
222 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 35 genes, 66 drugs (DrugBank) and 100 diseases |
EGFR [1] EGFR 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Erlotinib Erlotinib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Erlotinib | 094 [2] 94, 160 💬221. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
223 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 35 genes, 66 drugs (DrugBank) and 100 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Pimecrolimus | 160 [1] 160 💬223. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
224 | Pertussis 💬 22 genes, 46 drugs (DrugBank) and 73 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Pertussis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬224. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
225 | Pertussis 💬 22 genes, 46 drugs (DrugBank) and 73 diseases |
TNF [1] TNF 💬Pertussis
|
Adalimumab Adalimumab 💬Pertussis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬225. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
226 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
EGFR [1] EGFR 💬Phospholipase D signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Phospholipase D signaling pathway
| Erlotinib | 094 [2] 94, 160 💬226. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
227 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
EGFR [1] EGFR 💬Phospholipase D signaling pathway
|
Erlotinib Erlotinib 💬Phospholipase D signaling pathway
| Erlotinib | 094 [2] 94, 160 💬226. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
228 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR [1] EGFR 💬PI3K-Akt signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬PI3K-Akt signaling pathway
| Erlotinib | 094 [2] 94, 160 💬228. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
229 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
EGFR [1] EGFR 💬PI3K-Akt signaling pathway
|
Erlotinib Erlotinib 💬PI3K-Akt signaling pathway
| Erlotinib | 094 [2] 94, 160 💬228. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
230 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL4R [1] IL4R 💬PI3K-Akt signaling pathway
|
Dupilumab Dupilumab 💬PI3K-Akt signaling pathway
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬230. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
231 | PPAR signaling pathway 💬 12 genes, 18 drugs (DrugBank) and 35 diseases |
NR1C1 [1] NR1C1 💬PPAR signaling pathway
|
Bezafibrate Bezafibrate 💬PPAR signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬231. PPAR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
232 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Prion disease
| Pimecrolimus | 160 [1] 160 💬232. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
233 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
TNF [1] TNF 💬Prion disease
|
Adalimumab Adalimumab 💬Prion disease
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬233. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
234 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
EGFR [1] EGFR 💬Prostate cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Prostate cancer
| Erlotinib | 094 [2] 94, 160 💬234. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
235 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
EGFR [1] EGFR 💬Prostate cancer
|
Erlotinib Erlotinib 💬Prostate cancer
| Erlotinib | 094 [2] 94, 160 💬234. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
236 | Proteoglycans in cancer 💬 33 genes, 73 drugs (DrugBank) and 103 diseases |
EGFR [1] EGFR 💬Proteoglycans in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Proteoglycans in cancer
| Erlotinib | 094 [2] 94, 160 💬236. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
237 | Proteoglycans in cancer 💬 33 genes, 73 drugs (DrugBank) and 103 diseases |
EGFR [1] EGFR 💬Proteoglycans in cancer
|
Erlotinib Erlotinib 💬Proteoglycans in cancer
| Erlotinib | 094 [2] 94, 160 💬236. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
238 | Proteoglycans in cancer 💬 33 genes, 73 drugs (DrugBank) and 103 diseases |
IL12B [1] IL12B 💬Proteoglycans in cancer
|
Ustekinumab Ustekinumab 💬Proteoglycans in cancer
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬238. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
239 | Proteoglycans in cancer 💬 33 genes, 73 drugs (DrugBank) and 103 diseases |
TNF [1] TNF 💬Proteoglycans in cancer
|
Adalimumab Adalimumab 💬Proteoglycans in cancer
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬239. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
240 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
EGFR [1] EGFR 💬Rap1 signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Rap1 signaling pathway
| Erlotinib | 094 [2] 94, 160 💬240. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
241 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
EGFR [1] EGFR 💬Rap1 signaling pathway
|
Erlotinib Erlotinib 💬Rap1 signaling pathway
| Erlotinib | 094 [2] 94, 160 💬240. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
242 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Ras signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Ras signaling pathway
| Erlotinib | 094 [2] 94, 160 💬242. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
243 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Ras signaling pathway
|
Erlotinib Erlotinib 💬Ras signaling pathway
| Erlotinib | 094 [2] 94, 160 💬242. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
244 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
EGFR [1] EGFR 💬Regulation of actin cytoskeleton
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Regulation of actin cytoskeleton
| Erlotinib | 094 [2] 94, 160 💬244. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
245 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
EGFR [1] EGFR 💬Regulation of actin cytoskeleton
|
Erlotinib Erlotinib 💬Regulation of actin cytoskeleton
| Erlotinib | 094 [2] 94, 160 💬244. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
246 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Relaxin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬246. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
247 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Erlotinib Erlotinib 💬Relaxin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬246. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
248 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Renin secretion
| Pimecrolimus | 160 [1] 160 💬248. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
249 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Rheumatoid arthritis
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬249. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
250 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
IL17A [1] IL17A 💬Rheumatoid arthritis
|
Ixekizumab Ixekizumab 💬Rheumatoid arthritis
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬250. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
251 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
IL17A [1] IL17A 💬Rheumatoid arthritis
|
Secukinumab Secukinumab 💬Rheumatoid arthritis
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬251. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
252 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
IL23A [1] IL23A 💬Rheumatoid arthritis
|
Ustekinumab Ustekinumab 💬Rheumatoid arthritis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬252. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
253 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Rheumatoid arthritis
|
Adalimumab Adalimumab 💬Rheumatoid arthritis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬253. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
254 | RIG-I-like receptor signaling pathway 💬 24 genes, 20 drugs (DrugBank) and 57 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬RIG-I-like receptor signaling pathway
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬254. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
255 | RIG-I-like receptor signaling pathway 💬 24 genes, 20 drugs (DrugBank) and 57 diseases |
TNF [1] TNF 💬RIG-I-like receptor signaling pathway
|
Adalimumab Adalimumab 💬RIG-I-like receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬255. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
256 | Salmonella infection 💬 30 genes, 46 drugs (DrugBank) and 75 diseases |
TNF [1] TNF 💬Salmonella infection
|
Adalimumab Adalimumab 💬Salmonella infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬256. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
257 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
ALOX5 [1] ALOX5 💬Serotonergic synapse
|
Zileuton Zileuton 💬Serotonergic synapse
| Zileuton | 085 [3] 85, 160, 164 💬257. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
258 | Shigellosis 💬 29 genes, 51 drugs (DrugBank) and 92 diseases |
EGFR [1] EGFR 💬Shigellosis
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Shigellosis
| Erlotinib | 094 [2] 94, 160 💬258. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
259 | Shigellosis 💬 29 genes, 51 drugs (DrugBank) and 92 diseases |
EGFR [1] EGFR 💬Shigellosis
|
Erlotinib Erlotinib 💬Shigellosis
| Erlotinib | 094 [2] 94, 160 💬258. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
260 | Shigellosis 💬 29 genes, 51 drugs (DrugBank) and 92 diseases |
TNF [1] TNF 💬Shigellosis
|
Adalimumab Adalimumab 💬Shigellosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬260. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
261 | Small cell lung cancer 💬 16 genes, 43 drugs (DrugBank) and 64 diseases |
RARB [1] RARB 💬Small cell lung cancer
|
Isotretinoin Isotretinoin 💬Small cell lung cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬261. Small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
262 | Sphingolipid signaling pathway 💬 32 genes, 57 drugs (DrugBank) and 80 diseases |
TNF [1] TNF 💬Sphingolipid signaling pathway
|
Adalimumab Adalimumab 💬Sphingolipid signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬262. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
263 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Systemic lupus erythematosus
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬263. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
264 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
TNF [1] TNF 💬Systemic lupus erythematosus
|
Adalimumab Adalimumab 💬Systemic lupus erythematosus
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬264. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
265 | T cell receptor signaling pathway 💬 38 genes, 59 drugs (DrugBank) and 84 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬T cell receptor signaling pathway
| Pimecrolimus | 160 [1] 160 💬265. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
266 | T cell receptor signaling pathway 💬 38 genes, 59 drugs (DrugBank) and 84 diseases |
TNF [1] TNF 💬T cell receptor signaling pathway
|
Adalimumab Adalimumab 💬T cell receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬266. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
267 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 56 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Atorvastatin calcium Atorvastatin calcium 💬Terpenoid backbone biosynthesis
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬267. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
268 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 56 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Atorvastatin Atorvastatin 💬Terpenoid backbone biosynthesis
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬267. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
269 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 56 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Lovastatin Lovastatin 💬Terpenoid backbone biosynthesis
| Lovastatin | 006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬269. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
270 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 56 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Simvastatin Simvastatin 💬Terpenoid backbone biosynthesis
| Simvastatin | 006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬270. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
271 | TGF-beta signaling pathway 💬 14 genes, 27 drugs (DrugBank) and 65 diseases |
TNF [1] TNF 💬TGF-beta signaling pathway
|
Adalimumab Adalimumab 💬TGF-beta signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬271. TGF-beta signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
272 | Th1 and Th2 cell differentiation 💬 46 genes, 51 drugs (DrugBank) and 77 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Th1 and Th2 cell differentiation
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬272. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
273 | Th1 and Th2 cell differentiation 💬 46 genes, 51 drugs (DrugBank) and 77 diseases |
IL4R [1] IL4R 💬Th1 and Th2 cell differentiation
|
Dupilumab Dupilumab 💬Th1 and Th2 cell differentiation
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬273. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
274 | Th1 and Th2 cell differentiation 💬 46 genes, 51 drugs (DrugBank) and 77 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Th1 and Th2 cell differentiation
| Pimecrolimus | 160 [1] 160 💬274. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
275 | Th1 and Th2 cell differentiation 💬 46 genes, 51 drugs (DrugBank) and 77 diseases |
TYK2 [1] TYK2 💬Th1 and Th2 cell differentiation
|
Deucravacitinib Deucravacitinib 💬Th1 and Th2 cell differentiation
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬275. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
276 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
IL17A [1] IL17A 💬Th17 cell differentiation
|
Ixekizumab Ixekizumab 💬Th17 cell differentiation
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬276. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
277 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
IL17A [1] IL17A 💬Th17 cell differentiation
|
Secukinumab Secukinumab 💬Th17 cell differentiation
| Secukinumab | 013 [8] 13, 37, 41, 46, 107, 160, 269, 271 💬277. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
278 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
IL23A [1] IL23A 💬Th17 cell differentiation
|
Ustekinumab Ustekinumab 💬Th17 cell differentiation
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬278. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
279 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
IL4R [1] IL4R 💬Th17 cell differentiation
|
Dupilumab Dupilumab 💬Th17 cell differentiation
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬279. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
280 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Th17 cell differentiation
| Pimecrolimus | 160 [1] 160 💬280. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
281 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
RARA [1] RARA 💬Th17 cell differentiation
|
Isotretinoin Isotretinoin 💬Th17 cell differentiation
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬281. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
282 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
TYK2 [1] TYK2 💬Th17 cell differentiation
|
Deucravacitinib Deucravacitinib 💬Th17 cell differentiation
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬282. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
283 | TNF signaling pathway 💬 23 genes, 61 drugs (DrugBank) and 90 diseases |
TNF [1] TNF 💬TNF signaling pathway
|
Adalimumab Adalimumab 💬TNF signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬283. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
284 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Toll-like receptor signaling pathway
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬284. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
285 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Toll-like receptor signaling pathway
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬285. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
286 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
TNF [1] TNF 💬Toll-like receptor signaling pathway
|
Adalimumab Adalimumab 💬Toll-like receptor signaling pathway
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬286. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
287 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
TYK2 [1] TYK2 💬Toll-like receptor signaling pathway
|
Deucravacitinib Deucravacitinib 💬Toll-like receptor signaling pathway
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬287. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
288 | Toxoplasmosis 💬 41 genes, 49 drugs (DrugBank) and 76 diseases |
ALOX5 [1] ALOX5 💬Toxoplasmosis
|
Zileuton Zileuton 💬Toxoplasmosis
| Zileuton | 085 [3] 85, 160, 164 💬288. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
289 | Toxoplasmosis 💬 41 genes, 49 drugs (DrugBank) and 76 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Toxoplasmosis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬289. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
290 | Toxoplasmosis 💬 41 genes, 49 drugs (DrugBank) and 76 diseases |
TNF [1] TNF 💬Toxoplasmosis
|
Adalimumab Adalimumab 💬Toxoplasmosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬290. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
291 | Toxoplasmosis 💬 41 genes, 49 drugs (DrugBank) and 76 diseases |
TYK2 [1] TYK2 💬Toxoplasmosis
|
Deucravacitinib Deucravacitinib 💬Toxoplasmosis
| Deucravacitinib | 036 [9] 36, 37, 49, 53, 84, 96, 97, 160, 269 💬291. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
292 | Transcriptional misregulation in cancer 💬 28 genes, 60 drugs (DrugBank) and 79 diseases |
CD86 [1] CD86 💬Transcriptional misregulation in cancer
|
Abatacept Abatacept 💬Transcriptional misregulation in cancer
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬292. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
293 | Transcriptional misregulation in cancer 💬 28 genes, 60 drugs (DrugBank) and 79 diseases |
RARA [1] RARA 💬Transcriptional misregulation in cancer
|
Isotretinoin Isotretinoin 💬Transcriptional misregulation in cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬293. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
294 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Tuberculosis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬294. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
295 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Tuberculosis
| Pimecrolimus | 160 [1] 160 💬295. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
296 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
TNF [1] TNF 💬Tuberculosis
|
Adalimumab Adalimumab 💬Tuberculosis
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬296. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
297 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 70 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Type I diabetes mellitus
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬297. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
298 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 70 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Type I diabetes mellitus
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬298. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
299 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 70 diseases |
TNF [1] TNF 💬Type I diabetes mellitus
|
Adalimumab Adalimumab 💬Type I diabetes mellitus
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬299. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
300 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
TNF [1] TNF 💬Type II diabetes mellitus
|
Adalimumab Adalimumab 💬Type II diabetes mellitus
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬300. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
301 | VEGF signaling pathway 💬 23 genes, 56 drugs (DrugBank) and 94 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬VEGF signaling pathway
| Pimecrolimus | 160 [1] 160 💬301. VEGF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
302 | Viral myocarditis 💬 34 genes, 27 drugs (DrugBank) and 52 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Viral myocarditis
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬302. Viral myocarditis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
303 | Viral protein interaction with cytokine and cytokine receptor 💬 17 genes, 32 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Viral protein interaction with cytokine and cytokine receptor
|
Adalimumab Adalimumab 💬Viral protein interaction with cytokine and cytokine receptor
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬303. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
304 | Virion - Adenovirus 💬 2 genes, 2 drugs (DrugBank) and 27 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Virion - Adenovirus
| Abatacept | 002 [27] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬304. Virion - Adenovirus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
305 | Virion - Hepatitis viruses 💬 3 genes, 12 drugs (DrugBank) and 18 diseases |
EGFR [1] EGFR 💬Virion - Hepatitis viruses
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Virion - Hepatitis viruses
| Erlotinib | 094 [2] 94, 160 💬305. Virion - Hepatitis viruses
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
306 | Virion - Hepatitis viruses 💬 3 genes, 12 drugs (DrugBank) and 18 diseases |
EGFR [1] EGFR 💬Virion - Hepatitis viruses
|
Erlotinib Erlotinib 💬Virion - Hepatitis viruses
| Erlotinib | 094 [2] 94, 160 💬305. Virion - Hepatitis viruses
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
307 | Wnt signaling pathway 💬 10 genes, 11 drugs (DrugBank) and 59 diseases |
PPP3C [5] PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
|
Pimecrolimus Pimecrolimus 💬Wnt signaling pathway
| Pimecrolimus | 160 [1] 160 💬307. Wnt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
308 | Yersinia infection 💬 27 genes, 45 drugs (DrugBank) and 79 diseases |
TNF [1] TNF 💬Yersinia infection
|
Adalimumab Adalimumab 💬Yersinia infection
| Adalimumab | 019 [21] 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬308. Yersinia infection
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
Adherens junction
12 genes, 24 drugs (DrugBank) and 29 diseases
Adipocytokine signaling pathway
16 genes, 38 drugs (DrugBank) and 104 diseases
African trypanosomiasis
10 genes, 24 drugs (DrugBank) and 62 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Alcoholic liver disease
42 genes, 54 drugs (DrugBank) and 91 diseases
Allograft rejection
31 genes, 26 drugs (DrugBank) and 60 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 71 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
AMPK signaling pathway
16 genes, 56 drugs (DrugBank) and 95 diseases
Amyotrophic lateral sclerosis
38 genes, 55 drugs (DrugBank) and 109 diseases
Antigen processing and presentation
26 genes, 17 drugs (DrugBank) and 61 diseases
Apoptosis
17 genes, 31 drugs (DrugBank) and 64 diseases
Arachidonic acid metabolism
5 genes, 25 drugs (DrugBank) and 44 diseases
Asthma
21 genes, 25 drugs (DrugBank) and 58 diseases
Autoimmune thyroid disease
42 genes, 18 drugs (DrugBank) and 37 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 75 diseases
B cell receptor signaling pathway
19 genes, 39 drugs (DrugBank) and 68 diseases
Bile secretion
14 genes, 36 drugs (DrugBank) and 61 diseases
Bladder cancer
11 genes, 27 drugs (DrugBank) and 33 diseases
Breast cancer
22 genes, 63 drugs (DrugBank) and 80 diseases
C-type lectin receptor signaling pathway
27 genes, 66 drugs (DrugBank) and 102 diseases
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
Cell adhesion molecules
43 genes, 34 drugs (DrugBank) and 43 diseases
Cellular senescence
34 genes, 46 drugs (DrugBank) and 96 diseases
Central carbon metabolism in cancer
19 genes, 37 drugs (DrugBank) and 65 diseases
cGMP-PKG signaling pathway
49 genes, 132 drugs (DrugBank) and 124 diseases
Chagas disease
31 genes, 56 drugs (DrugBank) and 87 diseases
Chemical carcinogenesis - reactive oxygen species
25 genes, 39 drugs (DrugBank) and 51 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Choline metabolism in cancer
11 genes, 30 drugs (DrugBank) and 61 diseases
Colorectal cancer
14 genes, 26 drugs (DrugBank) and 59 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Cushing syndrome
24 genes, 55 drugs (DrugBank) and 71 diseases
Cytokine-cytokine receptor interaction
89 genes, 142 drugs (DrugBank) and 110 diseases
Diabetic cardiomyopathy
28 genes, 48 drugs (DrugBank) and 79 diseases
Dilated cardiomyopathy
24 genes, 61 drugs (DrugBank) and 88 diseases
Dopaminergic synapse
31 genes, 102 drugs (DrugBank) and 104 diseases
Efferocytosis
29 genes, 74 drugs (DrugBank) and 93 diseases
Endocytosis
22 genes, 37 drugs (DrugBank) and 54 diseases
Endometrial cancer
10 genes, 20 drugs (DrugBank) and 28 diseases
Epithelial cell signaling in Helicobacter pylori infection
12 genes, 19 drugs (DrugBank) and 26 diseases
Epstein-Barr virus infection
67 genes, 90 drugs (DrugBank) and 82 diseases
ErbB signaling pathway
14 genes, 28 drugs (DrugBank) and 62 diseases
Estrogen signaling pathway
21 genes, 81 drugs (DrugBank) and 73 diseases
Fc epsilon RI signaling pathway
19 genes, 50 drugs (DrugBank) and 68 diseases
Fluid shear stress and atherosclerosis
34 genes, 59 drugs (DrugBank) and 93 diseases
Focal adhesion
31 genes, 51 drugs (DrugBank) and 52 diseases
FoxO signaling pathway
25 genes, 43 drugs (DrugBank) and 60 diseases
Gap junction
26 genes, 97 drugs (DrugBank) and 82 diseases
Gastric cancer
22 genes, 40 drugs (DrugBank) and 66 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 64 diseases
Glucagon signaling pathway
14 genes, 23 drugs (DrugBank) and 82 diseases
Glutamatergic synapse
23 genes, 30 drugs (DrugBank) and 81 diseases
GnRH signaling pathway
16 genes, 40 drugs (DrugBank) and 42 diseases
Graft-versus-host disease
28 genes, 25 drugs (DrugBank) and 64 diseases
Hematopoietic cell lineage
53 genes, 95 drugs (DrugBank) and 101 diseases
Hepatitis B
43 genes, 65 drugs (DrugBank) and 87 diseases
Hepatitis C
36 genes, 70 drugs (DrugBank) and 87 diseases
Hepatocellular carcinoma
21 genes, 32 drugs (DrugBank) and 67 diseases
Herpes simplex virus 1 infection
70 genes, 80 drugs (DrugBank) and 107 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human immunodeficiency virus 1 infection
50 genes, 57 drugs (DrugBank) and 95 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
Human T-cell leukemia virus 1 infection
59 genes, 74 drugs (DrugBank) and 96 diseases
Hypertrophic cardiomyopathy
27 genes, 57 drugs (DrugBank) and 90 diseases
IL-17 signaling pathway
20 genes, 61 drugs (DrugBank) and 86 diseases
Inflammatory bowel disease
37 genes, 46 drugs (DrugBank) and 70 diseases
Influenza A
65 genes, 78 drugs (DrugBank) and 98 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 100 diseases
Intestinal immune network for IgA production
33 genes, 40 drugs (DrugBank) and 51 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
Legionellosis
9 genes, 23 drugs (DrugBank) and 64 diseases
Leishmaniasis
40 genes, 68 drugs (DrugBank) and 102 diseases
Lipid and atherosclerosis
51 genes, 71 drugs (DrugBank) and 103 diseases
Long-term potentiation
18 genes, 36 drugs (DrugBank) and 86 diseases
Malaria
16 genes, 32 drugs (DrugBank) and 71 diseases
MAPK signaling pathway
65 genes, 98 drugs (DrugBank) and 109 diseases
Measles
42 genes, 63 drugs (DrugBank) and 68 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 42 diseases
MicroRNAs in cancer
33 genes, 75 drugs (DrugBank) and 90 diseases
mTOR signaling pathway
14 genes, 33 drugs (DrugBank) and 95 diseases
Natural killer cell mediated cytotoxicity
44 genes, 50 drugs (DrugBank) and 86 diseases
Necroptosis
32 genes, 52 drugs (DrugBank) and 77 diseases
NF-kappa B signaling pathway
22 genes, 77 drugs (DrugBank) and 91 diseases
NOD-like receptor signaling pathway
32 genes, 51 drugs (DrugBank) and 74 diseases
Non-alcoholic fatty liver disease
23 genes, 52 drugs (DrugBank) and 95 diseases
Non-small cell lung cancer
21 genes, 40 drugs (DrugBank) and 58 diseases
Oocyte meiosis
14 genes, 39 drugs (DrugBank) and 77 diseases
Osteoclast differentiation
38 genes, 86 drugs (DrugBank) and 102 diseases
Ovarian steroidogenesis
7 genes, 34 drugs (DrugBank) and 53 diseases
Oxytocin signaling pathway
35 genes, 80 drugs (DrugBank) and 110 diseases
Pancreatic cancer
19 genes, 40 drugs (DrugBank) and 84 diseases
Parathyroid hormone synthesis, secretion and action
22 genes, 58 drugs (DrugBank) and 72 diseases
Pathogenic Escherichia coli infection
28 genes, 43 drugs (DrugBank) and 78 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Pathways of neurodegeneration - multiple diseases
63 genes, 138 drugs (DrugBank) and 132 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
35 genes, 66 drugs (DrugBank) and 100 diseases
Pertussis
22 genes, 46 drugs (DrugBank) and 73 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
PPAR signaling pathway
12 genes, 18 drugs (DrugBank) and 35 diseases
Prion disease
41 genes, 74 drugs (DrugBank) and 114 diseases
Prostate cancer
24 genes, 57 drugs (DrugBank) and 89 diseases
Proteoglycans in cancer
33 genes, 73 drugs (DrugBank) and 103 diseases
Rap1 signaling pathway
45 genes, 113 drugs (DrugBank) and 98 diseases
Ras signaling pathway
37 genes, 64 drugs (DrugBank) and 70 diseases
Regulation of actin cytoskeleton
35 genes, 82 drugs (DrugBank) and 81 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 51 diseases
Renin secretion
28 genes, 87 drugs (DrugBank) and 113 diseases
Rheumatoid arthritis
38 genes, 59 drugs (DrugBank) and 87 diseases
RIG-I-like receptor signaling pathway
24 genes, 20 drugs (DrugBank) and 57 diseases
Salmonella infection
30 genes, 46 drugs (DrugBank) and 75 diseases
Serotonergic synapse
39 genes, 122 drugs (DrugBank) and 83 diseases
Shigellosis
29 genes, 51 drugs (DrugBank) and 92 diseases
Small cell lung cancer
16 genes, 43 drugs (DrugBank) and 64 diseases
Sphingolipid signaling pathway
32 genes, 57 drugs (DrugBank) and 80 diseases
Systemic lupus erythematosus
30 genes, 49 drugs (DrugBank) and 83 diseases
T cell receptor signaling pathway
38 genes, 59 drugs (DrugBank) and 84 diseases
Terpenoid backbone biosynthesis
4 genes, 14 drugs (DrugBank) and 56 diseases
TGF-beta signaling pathway
14 genes, 27 drugs (DrugBank) and 65 diseases
Th1 and Th2 cell differentiation
46 genes, 51 drugs (DrugBank) and 77 diseases
Th17 cell differentiation
56 genes, 80 drugs (DrugBank) and 108 diseases
TNF signaling pathway
23 genes, 61 drugs (DrugBank) and 90 diseases
Toll-like receptor signaling pathway
41 genes, 65 drugs (DrugBank) and 79 diseases
Toxoplasmosis
41 genes, 49 drugs (DrugBank) and 76 diseases
Transcriptional misregulation in cancer
28 genes, 60 drugs (DrugBank) and 79 diseases
Tuberculosis
66 genes, 73 drugs (DrugBank) and 98 diseases
Type I diabetes mellitus
32 genes, 25 drugs (DrugBank) and 70 diseases
Type II diabetes mellitus
14 genes, 42 drugs (DrugBank) and 94 diseases
VEGF signaling pathway
23 genes, 56 drugs (DrugBank) and 94 diseases
Viral myocarditis
34 genes, 27 drugs (DrugBank) and 52 diseases
Viral protein interaction with cytokine and cytokine receptor
17 genes, 32 drugs (DrugBank) and 68 diseases
Virion - Adenovirus
2 genes, 2 drugs (DrugBank) and 27 diseases
Virion - Hepatitis viruses
3 genes, 12 drugs (DrugBank) and 18 diseases
Wnt signaling pathway
10 genes, 11 drugs (DrugBank) and 59 diseases
Yersinia infection
27 genes, 45 drugs (DrugBank) and 79 diseases